Clinicopathological and Epidemiological Characteristics of Esophageal and GE- Junction Cancers in Kabul, Afghanistan: A Cross-Sectional Study
Main Article Content
Abstract
Abstract
Introduction: Esophageal cancer (EC) represents a significant global health burden, characterized by diverse geographical and histological patterns. A comprehensive understanding of local epidemiological profiles is paramount for developing effective prevention and management strategies. This study aimed to delineate the clinicodemographic features, histological distribution, and treatment responses of esophageal and gastroesophageal junction (GEJ) cancers in Kabul, Afghanistan, and to contextualize these findings against global data.
Methods: A retrospective cross-sectional study was conducted from January 2023 to December 2024 at Nasir Pathology Laboratory, encompassing 104 patients with histopathologically confirmed esophageal or GEJ carcinoma. Retrospective analysis was performed on data pertaining to patient demographics, substance use history, tumor characteristics, and treatment outcomes.
Results: The study population had a mean age of 59 years, with a notable male predominance (70.2%). Esophageal tumors constituted 75% of cases, while GEJ tumors accounted for 25%. Esophageal squamous cell carcinoma (ESCC) was the predominant histological subtype (55.8%), followed by esophageal adenocarcinoma (EAC) (42.3%). The overall positive treatment response rate was 48.1%. No statistically significant associations were identified between variables and tumor site or treatment outcome (P>0.05). However, observed trends included a higher treatment response for EAC (54.5%) compared to ESCC (41.4%), and a high prevalence of substance use (60%) among patients.
Conclusion: The findings suggest that Kabul exhibits a transitional EC epidemiological profile, characterized by the persistent dominance of ESCC alongside a substantial presence of EAC, indicative of evolving risk factors. The high prevalence of substance use underscores its critical role as a regional etiological factor. While acknowledging the limitations imposed by sample size, these results significantly contribute to the local understanding of EC and can inform national cancer control strategies.
Keywords: Esophageal cancer, GE-junction cancer, Clinicopathological characteristics, Epidemiological characteristics.
Article Details
References
1. Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163(3):649-58. e2.
2. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-63.
3. Fan J, Liu Z, Mao X, Tong X, Zhang T, Suo C, et al. Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017. Cancer Med. 2020;9(18):6875-87.
4. Li J, Xu J, Zheng Y, Gao Y, He S, Li H, et al. Esophageal cancer: Epidemiology, risk factors and screening. Chinese J Cancer Res. 2021;33(5):535.
5. Zhang C, Chen L, Xiu Y, Zhang H, Zhang Y, Ying W. Burden of esophageal cancer in global, regional and national regions from 1990 to 2021 and its projection until 2050: results from the GBD study 2021. Front Oncol. 2025;14:1518567.
6. Trivers KF, Sabatino SA, Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998–2003. Int J Cancer. 2008;123(6):1422-8.
7. Cattelan L, Ghazawi FM, Le M, Lagacé F, Savin E, Zubarev A, et al. Epidemiologic trends and geographic distribution of esophageal cancer in Canada: a national population‐based study. Cancer Med. 2020;9(1):401-17.
8. Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol. 2013;19(34):5598.
9. Schaafsma T, Wakefield J, Hanisch R, Bray F, Schüz J, Joy EJ, et al. Africa’s oesophageal cancer corridor: geographic variations in incidence correlate with certain micronutrient deficiencies. PloS One. 2015;10(10):e0140107.
10. Loomis D, Guyton KZ, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, et al. Carcinogenicity of drinking coffee, mate, and very hot beverages. Lancet Oncol. 2016;17(7):877-8.
11. Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Eng J Med. 2011;365(15):1375-83.
12. Melhado RE, Alderson D, Tucker O. The changing face of esophageal cancer. Cancers. 2010;2(3):1379-404.
13. Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, Abnet C, et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer. 2008;98(11):1857-63.
14. Mlombe Y, Rosenberg N, Wolf L, Dzamalala C, Chalulu K, Chisi J, et al. Environmental risk factors for oesophageal cancer in Malawi: A case-control study. Malawi Med J. 2015;27(3):88.
15. Talukdar FR, di Pietro M, Secrier M, Moehler M, Goepfert K, Lima SSC, et al. Molecular landscape of esophageal cancer: implications for early detection and personalized therapy. Annals of the New York Academy of Sciences. 2018;1434(1):342-59.
16. Siewert J, Stein H. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998;85(11):1457.
17. Rice TW, Ishwaran H, Ferguson MK, Blackstone EH, Goldstraw P. Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thoracic Oncol. 2017;12(1):36-42.
18. Saadaat R, Abdul-Ghafar J, Haidary AM, Atta N, Ali TS. Esophageal carcinoma and associated risk factors: A case-control study in two tertiary care hospitals of Kabul, Afghanistan. Cancer Manag Res. 2022:2445-56.
19. Tawakoli MF, Salihee H, Rahmati A, Hatami MN. Hospital-based patterns of esophageal and gastric cancer cases at a major tertiary referral center in Kabul, Afghanistan: a retrospective case series. BMC Cancer. 2026.
20. Steliarova-Foucher E, Colombet M, Ries LA, Rous B, Stiller CA. Classification of tumours. International Incidence Childhood Cancer. 2017;3:31-6.
21. Then EO, Lopez M, Saleem S, Gayam V, Sunkara T, Culliford A, et al. Esophageal cancer: an updated surveillance epidemiology and end results database analysis. World J Oncol. 2020;11(2):55.
22. Saadaat R, Abdul-Ghafar J, Hanifi AN, Khalid S, Khairy AL, Ibrahimkhil AS, et al. Risk factors associated with esophageal cancers, diagnosed at tertiary level in Afghanistan: a descriptive cross-sectional study. BMC Cancer. 2022;22(1):1112.
23. Liang H, Fan J-H, Qiao Y-L. Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol Med. 2017;14(1):33-41.
24. Noronha V, Sekar A, Rajendra A, Mokal S, Patil V, Menon N, et al. Epidemiological trend of esophageal cancer at a tertiary cancer center in Mumbai, India, over the past 15 years. J Gastrointest Cancer. 2023;54(3):903-12.
25. Huang J, Koulaouzidis A, Marlicz W, Lok V, Chu C, Ngai CH, et al. Global burden, risk factors, and trends of esophageal cancer: an analysis of cancer registries from 48 countries. Cancers. 2021;13(1):141.
26. Gammon MD, Ahsan H, Schoenberg JB, West AB, Rotterdam H, Niwa S, et al. Tobacco, Alcohol, and Socioeconomic Status and Adenocarcinomas of the Esophagus and Gastric Cardia. J Nati Cancer Inst. 1997;89(17):1277-84.
27. Esther N, Julius S, Deogratius MA. Understanding health-seeking and adherence to treatment by patients with esophageal cancer at the Uganda cancer Institute: a qualitative study. BMC Health Serv Res. 2021;21(1):159.
28. Hassen HY, Teka MA, Addisse A. Survival Status of Esophageal Cancer Patients and its Determinants in Ethiopia: A Facility Based Retrospective Cohort Study. Front Oncol. 2020;10:594342.